HRTX FY 2015 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$153M

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$734,000

Operating Income

-$97M

Net Income

-$98M

EPS (Diluted)

$-2.95

Cash Flow

Operating Cash Flow

-$79M

Free Cash Flow

-$80M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$138M

Total Liabilities

$20M

Stockholders' Equity

$118M

Cash & Equivalents

$75M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$734,000	-$55M	+98.7%
Operating Income	-$97M	-$75M	-30.0%
Net Income	-$98M	-$76M	-27.8%